Eltrombopag Olamine Tablets 25 mg | LTROLAMINE 25

Description

LTROLAMINE 25 is a prescription medicine containing Eltrombopag Olamine Tablets 25 mg, developed to support patients with low platelet counts (thrombocytopenia). Platelets play a crucial role in blood clotting, and reduced platelet levels can increase the risk of bleeding and bruising. LTROLAMINE 25 works by stimulating platelet production in the bone marrow, helping the body maintain healthier platelet levels. This medicine is commonly prescribed for chronic blood-related conditions where platelet counts remain persistently low and interfere with daily life or medical treatment plans. Uses Eltrombopag Olamine Tablets 25 mg are mainly used for: Treatment of chronic immune thrombocytopenia (ITP) in adults and children who have not responded adequately to other treatments. Management of low platelet counts in patients with chronic hepatitis C, especially when thrombocytopenia limits antiviral therapy. Supportive treatment for severe aplastic anaemia in patients who have not responded to immunosuppressive therapy. LTROLAMINE 25 helps reduce the risk of bleeding by improving platelet levels over time under medical supervision. Benefits LTROLAMINE 25 offers several important benefits for patients dealing with chronic thrombocytopenia: Helps increase platelet production naturally by stimulating thrombopoietin receptors. Reduces the risk of excessive bleeding, bruising, and nosebleeds. Supports continuation of essential medical treatments that require adequate platelet levels. Improves overall quality of life by maintaining stable platelet counts. Suitable for long-term management when taken as prescribed by a healthcare professional. Its targeted mechanism makes it an effective option in carefully selected patients. Dosage The dosage of LTROLAMINE 25 (Eltrombopag Olamine Tablets 25 mg) depends on the patient’s age, medical condition, platelet count, and response to treatment. The tablet is usually taken once daily, preferably on an empty stomach. It should be taken at least 2 hours before or 4 hours after foods or supplements containing calcium, iron, magnesium, aluminium, or zinc. Regular blood tests are required to monitor platelet levels and liver function. Dosage adjustments should only be made by a doctor. Patients should never increase or stop the medicine without medical advice. Side Effects Like all medicines, LTROLAMINE 25 may cause side effects, although not everyone experiences them. Commonly reported side effects include: Headache Nausea or vomiting Diarrhoea Fatigue Muscle pain Less common but serious side effects may include: Abnormal liver function tests Blood clot formation if platelet counts rise excessively Allergic reactions Patients should inform their doctor immediately if they notice unusual symptoms or signs of liver problems. Precautions and Warning Before using LTROLAMINE 25, patients should inform their doctor about: Any existing liver disease History of blood clots or cardiovascular conditions Pregnancy or breastfeeding All other medicines, supplements, or herbal products being taken Regular monitoring of platelet count and liver enzymes is essential during treatment. This medicine should be used strictly under medical supervision and is not recommended for self-medication. Conclusion LTROLAMINE 25, containing Eltrombopag Olamine Tablets 25 mg, is an effective and well-established treatment option for managing chronic low platelet conditions such as immune thrombocytopenia and aplastic anaemia. By promoting healthy platelet production, it helps reduce bleeding risks and supports long-term disease management. When taken as prescribed and monitored regularly, LTROLAMINE 25 can play a vital role in improving patient safety and quality of life. Always consult a healthcare professional for proper guidance and individualized treatment planning.